Association of SRXN1 Receptor Gene Polymorphism with Susceptibility to Periodontitis

Overview

Journal Contemp Clin Dent

Specialty Dentistry

Date 2023 Jan 23

PMID 36686993

Authors

Karthikeyan Murthykumar

Sheeja Varghese

Vijayashree Priyadharsini Jayaseelan

Affiliations

Soon will be listed here.

Abstract

Background: Emerging evidence suggests that oxidative stress forms a key component in the etiopathogenesis of periodontitis. Literature evidence have shown potential antioxidants responsible for combating the pro-oxidants which stress the periodontium, but the peroxiredoxin-sulfiredoxin system is explored very minimally in periodontal disease. Thus, the present study was aimed to evaluate the genetic association of SRXN1 receptor gene polymorphism (rs6053666).

Materials And Methods: A total of 100 subjects were recruited for this study, which included 50 Periodontitis patients (Stage II and above based on the criteria of American Association of Periodontology-2018) and 50 periodontally healthy or mild gingivitis. Genomic DNA was extracted from the whole blood collected from the subjects. DNA was amplified using specific primers flanking the BtgI region of the SRXN1 receptor gene. The amplicon was further subjected to genotyping using restriction fragment length using BtgI enzyme. The genotype obtained based on the restriction fragment length polymorphism pattern was recorded and used for statistical analysis. The distribution of genotypes and allele frequencies in the periodontitis and control groups were compared using the Chi-square test. The risk associated with individual alleles or genotypes was calculated as the odds ratio with 95% confidence intervals. Statistical significance in all tests was determined at < 0.05.

Results: The genotype frequency and distributions of SRXN1 receptor BtgI polymorphism did not differ significantly at ꭕ2df ( = 0.557). Our study results showed that homozygous and heterozygous mutant genotypes had no significant difference (CC vs. CT + TT) between the periodontitis patients and control group with a = 0.4266. The detected frequency of CT (38% vs. 34%) and TT (42% vs. 52%) genotype showed no significant difference between control and test group. There was no significant difference in C allele (39% vs. 31%) and T allele (61% vs. 69%) between the test and control group.

Conclusion: The present study denotes that SRXN1 receptor gene polymorphism is not associated with periodontitis in the study group analyzed.

Citing Articles

Gingival acquired lymphangiectasia as a long-term effect of post-oncology intervention: A 20-year institutional audit.

Ramani P, Ramasubramanian A, Kizhakkoottu S, Benitha G J Oral Maxillofac Pathol. 2024; 28(3):428-433.

PMID: 39670122 PMC: 11633911. DOI: 10.4103/jomfp.jomfp_26_24.

Computational Exploration of Single-Nucleotide Polymorphisms in the Human hRAS Gene: Implications and Insights.

Dakshitha S, Priya Dharshini B, Suresh V, Dilipan E Cureus. 2024; 16(1):e53119.

PMID: 38420094 PMC: 10899094. DOI: 10.7759/cureus.53119.

Genetic association between rs1695 in glutathione S-transferase P1 and risk of periodontitis: a pilot study.

Saravanan R, Pandi A, Murthykumar K, Selvi S, Arumugam P, Jayaseelan V Mol Biol Res Commun. 2023; 12(4):133-137.

PMID: 37886736 PMC: 10599595. DOI: 10.22099/mbrc.2023.46999.1815.

References

Duarte P, Napimoga M, Fagnani E, Santos V, Bastos M, Ribeiro F . The expression of antioxidant enzymes in the gingivae of type 2 diabetics with chronic periodontitis. Arch Oral Biol. 2011; 57(2):161-8. DOI: 10.1016/j.archoralbio.2011.08.007. View

Fischer B, Voynow J, Ghio A . COPD: balancing oxidants and antioxidants. Int J Chron Obstruct Pulmon Dis. 2015; 10:261-76. PMC: 4321570. DOI: 10.2147/COPD.S42414. View

Gomez R, Dutra W, Moreira P . Epigenetics and periodontal disease: future perspectives. Inflamm Res. 2009; 58(10):625-9. DOI: 10.1007/s00011-009-0041-7. View

Kim S, Kim O, Kim O, Kim Y, Chung H . Antioxidant profile of whole saliva after scaling and root planing in periodontal disease. J Periodontal Implant Sci. 2010; 40(4):164-71. PMC: 2931304. DOI: 10.5051/jpis.2010.40.4.164. View

Wu L, Jiang H, Chawsheen H, Mishra M, Young M, Gerard M . Tumor promoter-induced sulfiredoxin is required for mouse skin tumorigenesis. Carcinogenesis. 2014; 35(5):1177-84. PMC: 4004209. DOI: 10.1093/carcin/bgu035. View

Hartikainen J, Tengstrom M, Kosma V, Kinnula V, Mannermaa A, Soini Y . Genetic polymorphisms and protein expression of NRF2 and Sulfiredoxin predict survival outcomes in breast cancer. Cancer Res. 2012; 72(21):5537-46. DOI: 10.1158/0008-5472.CAN-12-1474. View

Soriano F, Leveille F, Papadia S, Higgins L, Varley J, Baxter P . Induction of sulfiredoxin expression and reduction of peroxiredoxin hyperoxidation by the neuroprotective Nrf2 activator 3H-1,2-dithiole-3-thione. J Neurochem. 2008; 107(2):533-43. PMC: 2635540. DOI: 10.1111/j.1471-4159.2008.05648.x. View

Bae S, Woo H, Sung S, Lee H, Lee S, Kil I . Induction of sulfiredoxin via an Nrf2-dependent pathway and hyperoxidation of peroxiredoxin III in the lungs of mice exposed to hyperoxia. Antioxid Redox Signal. 2008; 11(5):937-48. DOI: 10.1089/ars.2008.2325. View

Pihlstrom B, MCHUGH R, Oliphant T . Comparison of surgical and nonsurgical treatment of periodontal disease. A review of current studies and additional results after 61/2 years. J Clin Periodontol. 1983; 10(5):524-41. DOI: 10.1111/j.1600-051x.1983.tb02182.x. View

10.

Murthykumar K, Arjunkumar R, Jayaseelan V . Association of vitamin D receptor gene polymorphism (rs10735810) and chronic periodontitis. J Investig Clin Dent. 2019; 10(4):e12440. DOI: 10.1111/jicd.12440. View

11.

Tsai C, Chen H, Chen S, Ho Y, Ho K, Wu Y . Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res. 2005; 40(5):378-84. DOI: 10.1111/j.1600-0765.2005.00818.x. View

12.

Konopka T, Krol K, Kopec W, Gerber H . Total antioxidant status and 8-hydroxy-2'-deoxyguanosine levels in gingival and peripheral blood of periodontitis patients. Arch Immunol Ther Exp (Warsz). 2007; 55(6):417-22. PMC: 2766448. DOI: 10.1007/s00005-007-0047-1. View

13.

OBrien P . Peroxidases. Chem Biol Interact. 2001; 129(1-2):113-39. DOI: 10.1016/s0009-2797(00)00201-5. View

14.

Wei Q, Jiang H, Matthews C, Colburn N . Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies. Proc Natl Acad Sci U S A. 2008; 105(50):19738-43. PMC: 2604998. DOI: 10.1073/pnas.0810676105. View

15.

Pontes C, Gonzales J, Novaes Jr A, Junior M, Grisi M, Michel J . 'Interleukin-4 gene polymorphism and its relation to periodontal disease in a Brazilian population of African heritage'. J Dent. 2004; 32(3):241-6. DOI: 10.1016/j.jdent.2003.11.004. View

16.

Woo H, Jeong W, Chang T, Park K, Park S, Yang J . Reduction of cysteine sulfinic acid by sulfiredoxin is specific to 2-cys peroxiredoxins. J Biol Chem. 2004; 280(5):3125-8. DOI: 10.1074/jbc.C400496200. View

17.

Ramesh A, Varghese S, Doraiswamy J, Malaiappan S . Role of sulfiredoxin in systemic diseases influenced by oxidative stress. Redox Biol. 2014; 2:1023-8. PMC: 4215520. DOI: 10.1016/j.redox.2014.09.002. View

18.

Sies H . Oxidative stress: oxidants and antioxidants. Exp Physiol. 1997; 82(2):291-5. DOI: 10.1113/expphysiol.1997.sp004024. View

19.

Rhee S, Kang S, Chang T, Jeong W, Kim K . Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 2002; 52(1-2):35-41. DOI: 10.1080/15216540252774748. View

20.

Singh A, Ling G, Suhasini A, Zhang P, Yamamoto M, Navas-Acien A . Nrf2-dependent sulfiredoxin-1 expression protects against cigarette smoke-induced oxidative stress in lungs. Free Radic Biol Med. 2008; 46(3):376-86. PMC: 2828157. DOI: 10.1016/j.freeradbiomed.2008.10.026. View